Reflections: Reminiscence Therapy with People Diagnosed with Neurocognitive Disorders
$30.00
Presented by Dr. Stephanie JW. Ford & Kayla N. Wass, BA
This program was recorded on Wednesday, November 16, 2022
Access provided upon registration on “My Courses” page
The prevalence of neurocognitive disorders in America continues to grow. In the United States of America 6.5 million individuals will be diagnosed with a major neurocognitive disorder due to Alzheimer’s Disease (Alzheimer’s Association, 2022). When an individual is diagnosed with Alzheimer’s Disease or another neurocognitive disorder the person, their family, friends, and community members are impacted. Friends and neighbors often become caregivers to provide support to the individual and their family.
Participants will learn about reminiscence therapy (Westerhof, & Bohlmeijer, 2014) and the application of the therapy to support the wellbeing of individuals diagnosed with a neurocognitive disorder. Conference participants will learn how to assess if reminiscence therapy should be used with individuals diagnosed with a neurocognitive disorder. Individuals will learn how to use reminiscence therapy along with two interventions to support clients and their caregivers. One intervention will incorporate the use of technology in the therapeutic process. Participants will also learn how to employ the wellness wheel and wellness counseling (Clarke, et al. , 2016) in the therapeutic process to promote the wellbeing of the individual diagnosed with a neurocognitive disorder and their caregivers. A case study will be used to promote participants interaction, as they learn and apply reminiscence therapy to the case of Mae.
Access provided upon registration on “My Courses” page
This program, when attended in its entirety, offers 1.0 CEs for Psychologists, 1.0 IL CEUS for Counselors and Social Workers, or 1.0 BBS California CEUs for LPCCs, LPSW, and LMFTs.
Description
Presented by Dr. Stephanie JW. Ford & Kayla N. Wass, BA
This program was recorded on Wednesday, November 16, 2022
Access provided upon registration on “My Courses” page
The prevalence of neurocognitive disorders in America continues to grow. In the United States of America 6.5 million individuals will be diagnosed with a major neurocognitive disorder due to Alzheimer’s Disease (Alzheimer’s Association, 2022). When an individual is diagnosed with Alzheimer’s Disease or another neurocognitive disorder the person, their family, friends, and community members are impacted. Friends and neighbors often become caregivers to provide support to the individual and their family.
Participants will learn about reminiscence therapy (Westerhof, & Bohlmeijer, 2014) and the application of the therapy to support the wellbeing of individuals diagnosed with a neurocognitive disorder. Conference participants will learn how to assess if reminiscence therapy should be used with individuals diagnosed with a neurocognitive disorder. Individuals will learn how to use reminiscence therapy along with two interventions to support clients and their caregivers. One intervention will incorporate the use of technology in the therapeutic process. Participants will also learn how to employ the wellness wheel and wellness counseling (Clarke, et al. , 2016) in the therapeutic process to promote the wellbeing of the individual diagnosed with a neurocognitive disorder and their caregivers. A case study will be used to promote participants interaction, as they learn and apply reminiscence therapy to the case of Mae.
Access provided upon registration on “My Courses” page
This program, when attended in its entirety, offers 1.0 CEs for Psychologists, 1.0 IL CEUS for Counselors and Social Workers, or 1.0 BBS California CEUs for LPCCs, LPSW, and LMFTs.
